Emtricitabine /tenofovir alafenamide


( Last Updated : October 9, 2018)
Generic Name:
Emtricitabine /tenofovir alafenamide
Project Status:
Complete
Therapeutic Area:
HIV-1 infection
Manufacturer:
Gilead Sciences Canada, Inc.
Call for patient/clinician input open:
Brand Name:
Descovy
Project Line:
Reimbursement Review
Project Number:
SR0470-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
HIV-1 infection
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: